LACOSAMIDE 150 MG TABLET

Lacosamide
$0.2856per EA
High Outlier
DEA Schedule CV

Strength

150 mg/1

Manufacturer

Tris Pharma Inc

NDC

27808024501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

2/19/2025

Active Ingredients

LACOSAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208308

On Market Since

3/19/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-26.3%

5Y

N/A

All

-33.8%